Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome

Assiut University

Status and phase: Withdrawn; Phase 4

Conditions: Premature Birth

Treatments: Drug: L-Carnitine 1G/5mL Injection; Drug: Dexamethasone

Study type: Interventional

Funder types: Other

Identifiers

NCT03630367

LCPET

Details and patient eligibility

About

The aim of the present study was to investigate the efficacy of L-carnitine therapy on the occurrence and prognosis of respiratory distress syndrome

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pregnant women between 30-37 weeks
• singleton pregnancy

Exclusion criteria

• congenital malformed fetus
• Extreme premature

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

0 participants in 2 patient groups

study group

Experimental group

Description:

women will receive dexamethasone 8 mg intramuscular every 8 hours plus single injection of L-carnitine 1 gm slow intravenous

Treatment:

Drug: Dexamethasone

Drug: L-Carnitine 1G/5mL Injection

control group

Active Comparator group

Description:

women will receive dexamethasone 8 mg intramuscular every 8 hours plus single injection of saline 1 gm slow intravenous

Treatment:

Drug: Dexamethasone